RESISTANCE TO NATURAL-KILLER CELL-MEDIATED CYTOLYSIS BY A PLEIOTROPIC DRUG-RESISTANT HUMAN ERYTHROLEUKEMIA (K562-R) CELL-LINE
- 1 September 1986
- journal article
- research article
- Vol. 46 (9) , 4511-4515
Abstract
K562-R, a pleiotropic drug-resistant cell line established in vitro, and K562-S, the chemotherapy-sensitive parent line, were used as targets in the natural killer cell (NK) system. At each of the effector:target ratios studied, the K562-R demonstrated a decrease in their susceptibility to both unstimulated and interferon-activated NK cells, as compared to the K562-S line. This difference did not appear to be related to a variable expresson of NK target structures, as the number of effector:target conjugates was similar, and both lines competed equally well in cold target inhibition experiments. The K562-R cells were not resistant to complement or monocyte-mediated killing, suggesting a relatively specific resistance to cell-mediated killing. These results are compatible with an NK postbinding defect in the K562-R cells and suggest that greater tumorigenicity for pleiotropic drug-resistant cells may in part be due to altered susceptibility to host defense.This publication has 4 references indexed in Scilit:
- Role of nk cells in the antimetastatic effect of anticoagulant drugsInternational Journal of Cancer, 1984
- Variance in resistance to natural and antibody‐dependent cellular cytotoxicity and to complement‐mediated lysis among K562 linesInternational Journal of Cancer, 1983
- Variants from a MLV-induced lymphoma selected for decreased sensitivity to NK lysis.The Journal of Immunology, 1981
- Relationship of host immune status to tumor cell arrest, distribution, and survival in experimental metastasisCancer, 1977